Program Goal. Program Goal Disclaimer Overview.

Slides:

Advertisements

Similar presentations

The Nurse View Key Insights Along the CML Continuum

Advertisements

Challenges and Opportunities in the Management of ANCA-Associated Vasculitis.

Pharmacy Perspectives in Multiple Myeloma: Relapsed and/or Refractory Disease.

Clinical Considerations in the Management of EGFR-Mutated Advanced NSCLC.

Post-autologous Transplant Therapy for Hodgkin Lymphoma

Improving the Diagnosis and Treatment of Seizures in Long-term Care

Advances in Managing Inhibitors in Patients With Hemophilia A

Managing the Patient With Tuberous Sclerosis Complex

Glaucoma Progression.

The Nurse View.

Introduction. Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Endocrine System.

The Patient Journey to Remission in MDD: A Collaborative Approach

Current Controversies in Multiple Sclerosis Management

Charting Progress in MS Diagnosis and Treatment for Today and Tomorrow

Epilepsy Treatment Across the Spectrum

Disclaimer. LEGAL AND POLICY CONSIDERATIONS OF NALOXONE FOR OPIOID TOXICITY REVERSAL.

Program Goals. Implementing the Updated American Thyroid Association Guidelines and Recommendations for RAI-R DTC.

The Nurse View: Updates in the Management of Metastatic Colorectal Cancer.

The Cancer Pain Journey: Optimizing Identification and Management

Assessing Newer Treatment Approaches for Multiply Relapsed Multiple Myeloma.

Successful Obesity Management and Counseling:

The Vicious Cycle of Chronic Migraine How Can the Physician Help?

Lessons Learned In Opioid Treatment From the Pain Action Consulting Team.

Tailoring Hemophilia Prophylaxis Therapy

Managing Depression in Bipolar I Disorder

What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?

Best Practices in Metastatic Colorectal Cancer

Treatment Options to Consider

Are We Closer to Personalized Medicine in MS?

Moving Prostate Cancer Care Forward: Putting Lessons From New Orleans and Chicago Into Practice.

VTE Treatment Conventional Approach

Glaucoma: Detect, Diagnose, And Monitor The Silent Thief of Vision

Seizures in the Elderly: Treatment and Special Considerations

Management of Adolescents With Seizures

Contemporary Issues in Psoriasis Care: A Call to Action

Targeting Osteoporosis Therapies to Patients at Highest Risk for Fracture.

Managing Depression is a Team Effort:

Gene Therapy: Past, Present, and Future

Program Goals. Implementing the Updated American Thyroid Association Guidelines and Recommendations for RAI-R DTC.

Program Goals Disclaimer Overview Assessing Disease Activity.

Managing Adverse Events With New Oral Therapies in CLL

Expert Debate in MDD.

Program Goals Overview Glatiramer Acetate 3 Times a Week.

Charting Progress in MS Treatment:

Poor Response to Initial Therapy for Migraine

Case: A 28-Year-Old Man. When a 5-ASA Agent No Longer Maintains Remission in a Patient With Ulcerative Colitis.

Management of Systematic Lupus Erythematosus

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Navigating Treatment Options in PAH

Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.

CMV in the HSCT Recipient

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Considerations in Managing Seizures in Women

Program Goals Disclaimers Defining Refractory Seizures.

Breaking News in Pemphigus Vulgaris and the Latest Updates for Your Practice.

Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: Considerations for Previously Treated Disease.

Insulin in Diabetes Management: Effective Patient Selection Is Key

Critical Decision Points in Insomnia

Proteasome Inhibitors and Patients

Communicating With Your Patients About Major Depressive Disorder

Clinical Challenges and Updates in Managing Seizure Clusters

The Nurse View: Spotlight on Immune Checkpoint Inhibitors in Advanced Lung Cancer.

Oral Therapies in MS.

Prostacyclin Pathway Agents in Action

Issues in Patients With Severe Epilepsy

AMD Therapy: Where Are We Now and Where Are We Going?

Patient and Clinician Perspectives on Preventive Therapy for Migraine

Navigating the Journey

Case Study #1. Management of Heart Failure With Comorbidities: Challenging Cases for the Cardiologist.

Motor Fluctuations in PD

Presentation transcript:

Program Goal

Disclaimer

Overview

Case #1: Interferon for Initial Therapy

Case #1: Neurologic Exam

Case #1: Management

Case #1: Treatment Options

Case #1: Treatment Choice

Case #1: Adverse Effects

Case #2: Interferon for Switching Therapy

Case #2: Treatment Considerations

Case #2: Treatment Considerations (cont)

Case #2: Treatment Choices

Case #3: History of Multiple Medications

Case #3: Treatment Considerations

Case #3: Treatment Considerations (cont)

Case #3: Other Considerations

Interferon Therapy: Management Concerns

New Treatment Option: Pegylated Interferon

Monitoring

Abbreviations

References

References (cont)

References (cont)